U.S. regulators on Thursday approved the first drug to treat COVID-19: remdesivir, an antiviral medicine given to hospitalized patients through an IV.
Roche Holding AG Chief Executive Officer Severin Schwan discusses the antibody cocktail that the Swiss drugmaker is developing with Regeneron Pharmaceuticals Inc. to treat Covid-19.
Chief Executive Officer Dave Ricks discusses the pharmaceutical giant's approach to the U.S. Food and Drug Administration to authorize emergency use of its experimental Covid-19 antibody therapy.
The chair of the UK Vaccine Taskforce says there may never be a vaccine for coronavirus.
Mayo Clinic Vaccine Research Group Director Gregory Poland discuses a timeline for developing and distributing a Covid-19 vaccine, and examines the spike in coronavirus cases as portions of the U.S. economy reopen.
Johns Hopkins Assistant Professor of Emergency Medicine Lauren Sauer discusses use of an anti-inflammatory drug to treat Covid-19, and an increase in coronavirus cases in China and U.S. states.